Experimental studies have demonstrated that inhibiting the expression levels of EGFR and blocking its phosphorylation can suppress the release of exosomes from hypoxic tumor cells, thereby exerting significant therapeutic effects in the treatment of cancer [12]. This evidence concerns the gene EGFR and neoplasm.